STOCK TITAN

PetIQ, Inc. - PETQ STOCK NEWS

Welcome to our dedicated page for PetIQ news (Ticker: PETQ), a resource for investors and traders seeking the latest updates and insights on PetIQ stock.

PetIQ, Inc. (NASDAQ: PETQ) is a leading innovator in pet medication and wellness based in Eagle, Idaho. Founded with a mission to enhance the lives of pets by providing veterinarian-recommended products, PetIQ offers a diverse portfolio of pet health solutions. The company’s offerings include prescription medications, over-the-counter flea and tick preventatives, health and wellness supplements, and various treats for both dogs and cats.

PetIQ operates through two primary segments: Products and Services. The Products segment, which generates the majority of the company's revenue, features a range of proprietary brands including Minties®, Advecta®, PetAction®, VetIQ®, Delightibles®, and Betsy Farms®. These products are available nationwide through traditional retail and e-commerce channels, making quality pet care accessible and affordable.

The Services segment offers veterinary services through community clinics and wellness centers in over 2,600 retail partner locations across 41 states. This extensive reach ensures that pet owners can conveniently access essential veterinary care.

Recent financial results indicate robust growth and strategic progress. In the third quarter of 2023, PetIQ reported a 32.1% increase in net sales to $277.0 million compared to the prior year period. The Products segment experienced a 36.0% rise in net sales, driven by broad-based growth across product categories and sales channels. The company’s strategic acquisition of Rocco & Roxie LLC also contributed to the impressive performance. Gross profit surged by 43.0%, reflecting improved manufacturing efficiencies and a favorable product mix.

PetIQ has made significant strides in operational efficiency and financial health. The company's net leverage was reduced to a record low of 2.8x by the end of the third quarter of 2023, demonstrating strong cash generation and disciplined financial management.

Looking ahead, PetIQ aims to further enhance its market presence and operational capabilities. The company is optimizing its Services segment by closing underperforming wellness centers and investing in areas with high returns, such as mobile community clinics and strategic marketing initiatives for its manufactured brands.

For investors and stakeholders, PetIQ represents a dynamic and growing player in the pet care industry, committed to innovation, quality, and accessibility. For more detailed financial information and updates, visit PetIQ.com.

Rhea-AI Summary
PetIQ, Inc. reported a 19.6% increase in net sales for the full year 2023, surpassing $1.1 billion. Adjusted EBITDA exceeded guidance, with record cash from operations at $61.9 million. The company's strategic investments in marketing led to market share gains and higher consumption rates, supporting future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
-
Rhea-AI Summary
PetIQ, Inc. will report financial results for Q4 and full year 2023 on February 28, 2024. A conference call with the executive management team will discuss the results. Listeners can participate via phone or webcast. Telephonic playback available until March 20, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
conferences earnings
-
Rhea-AI Summary
PetIQ, Inc. (Nasdaq: PETQ) has launched the Portable Calming Diffuser for Dogs and Cats from its SENTRY® Calming line of pet care products. The diffuser uses scientifically proven pheromone technology to help pets feel calm and relaxed, especially during the holiday season. It lasts up to 30 days and provides an 11% savings over other leading diffusers on the market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.03%
Tags
none
Rhea-AI Summary
PETQ: PetIQ Reports Record Third Quarter 2023 Net Sales Increase of 32% to $277.0 Million, Raises 2023 Annual Outlook, and Announces Services Segment Optimization
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.1%
Tags
-
Rhea-AI Summary
PetIQ, Inc. to report Q3 financial results on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.86%
Tags
conferences earnings
-
Rhea-AI Summary
PetIQ reports record Q2 2023 net sales of $314.5M, exceeding guidance. Raises 2023 annual outlook. Q2 net income up 104.2% to $9.6M. Q2 adjusted EBITDA of $32.9M, a 36.3% increase. Net leverage down to 3.6x. Full-year net sales expected to be $1,010M to $1,050M, a 12.0% increase. Adjusted EBITDA expected to be $93M to $97M, a 22.0% increase.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.1%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.93%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.12%
Tags

FAQ

What is the current stock price of PetIQ (PETQ)?

The current stock price of PetIQ (PETQ) is $30.99 as of October 24, 2024.

What is the market cap of PetIQ (PETQ)?

The market cap of PetIQ (PETQ) is approximately 918.7M.

What products does PetIQ offer?

PetIQ offers a range of veterinarian-recommended products including prescription medications, OTC flea and tick preventatives, health and wellness supplements, and treats for dogs and cats.

Where are PetIQ products available?

PetIQ products are available nationally through traditional retail partners and e-commerce channels.

What are the main segments of PetIQ's business?

PetIQ operates in two main segments: Products and Services. The Products segment includes pet medications and wellness items, while the Services segment provides veterinary care through clinics and wellness centers.

How did PetIQ perform financially in recent quarters?

PetIQ reported a 32.1% increase in net sales to $277.0 million and a 43.0% rise in gross profit in the third quarter of 2023 compared to the prior year period.

What strategic initiatives has PetIQ undertaken?

PetIQ has focused on optimizing its Services segment by closing underperforming wellness centers and investing in high-return areas like mobile community clinics and marketing initiatives.

Where is PetIQ headquartered?

PetIQ is headquartered in Eagle, Idaho.

What partnerships does PetIQ have?

PetIQ distributes its products through major retail partners and operates over 2,600 veterinary clinics in retail locations across 41 states.

What are some of PetIQ's proprietary brands?

Some of PetIQ's proprietary brands include Minties®, Advecta®, PetAction®, VetIQ®, Delightibles®, and Betsy Farms®.

How does PetIQ ensure accessibility to pet care products?

PetIQ ensures accessibility by distributing its products through a wide network of retail partners and e-commerce channels, providing affordable and high-quality pet care solutions.

What is PetIQ's outlook for future growth?

PetIQ aims to enhance its market presence through strategic investments in marketing, product development, and optimization of its service offerings, focusing on areas with high returns.

PetIQ, Inc.

Nasdaq:PETQ

PETQ Rankings

PETQ Stock Data

918.69M
29.67M
7%
102%
3.42%
Drug Manufacturers - Specialty & Generic
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
EAGLE